Connecticut approves first medical marijuana research program | Wilton Bulletin
The Connecticut Department of Consumer Protection (DCP) announced today that Saint Francis Hospital and Medical Center’s medical marijuana research program has been approved by the state.
The primary goal of the research program is to compare the effectiveness of medical marijuana versus oxycodone in patients with post traumatic acute, subacute and chronic pain from multiple rib fractures.
“We’re pleased to see our research program move forward so quickly in Connecticut,” Jonathan A. Harris, consumer protection commissioner said. “Our Medical Marijuana Program has already given nearly 15,000 patients relief from severe debilitating conditions, and these research programs will provide medical professionals the information they need to help their patients make good healthcare decisions.”
Harris said he expects to see “more thoughtful programs like the one developed at Saint Francis to start here in Connecticut in the coming months, and look forward to the medical progress we can make for families suffering from severe illnesses in the state.”